Aethlon Medical (AEMD) Liabilities and Shareholders Equity (2011 - 2026)

Aethlon Medical (AEMD) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $6.3 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 13.95% year-over-year to $6.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.0 million (down 20.87% YoY) and the FY2026 annual result came in at $6.3 million, down 13.95% from the prior year.
• Liabilities and Shareholders Equity retreated to $6.3 million in Q1 2026, from $8.1 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $23.0 million in Q3 2022 to a low of $5.3 million in Q2 2025.
• A 5-year average of $12.1 million and a median of $10.4 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity jumped 82.0% — and 2025, when it tumbled 53.52%.
• Tracing AEMD's Liabilities and Shareholders Equity over 5 years: stood at $20.7 million in 2022, then slumped by 49.64% to $10.4 million in 2023, then sank by 37.48% to $6.5 million in 2024, then increased by 23.47% to $8.1 million in 2025, then retreated by 21.4% to $6.3 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $6.3 million (Q1 2026), $8.1 million (Q4 2025), and $7.3 million (Q3 2025), per Business Quant data.